Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: onr:"swepub:oai:gup.ub.gu.se/318557" > Treatment with Core...

1 of 1
Previous record
Next record
To hitlist

Details
MARC

Stenmark, FredrikGothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Univ Gothenburg, Sweden; Kalmar Cty Hosp, Sweden (author)

Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk

Article/chapterEnglish2022

Publisher, publication year, extent ...

2022-08-08
Medical Journals Sweden AB,2022

Numbers

LIBRIS-ID:oai:gup.ub.gu.se/318557
https://gup.ub.gu.se/publication/318557URI
https://doi.org/10.1080/21681805.2022.2108139DOI
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-187723URI

Supplementary language notes

Language:English

Part of subdatabase

SwePubSwePub

Classification

Subject category:ref swepub-contenttype
Subject category:art swepub-publicationtype

Notes

Introduction CoreTherm (ProstaLund AB, Lund, Sweden) is an outpatient treatment option in men with lower urinary tract symptoms and catheter-dependent men with chronic urinary retention caused by benign prostatic obstruction (BPO). CoreTherm is high-energy transurethral microwave thermotherapy with feedback technique. Modern treatment with CoreTherm includes transurethral intraprostatic injections of mepivacaine and adrenaline via the Schelin Catheter (ProstaLund AB, Lund, Sweden) and is often referred to as the CoreTherm Concept. Objectives The aim of this study was to evaluate the short- and long-term retreatment risk in men with large prostates and BPO or chronic urinary retention, all primarily treated with CoreTherm. Material and Methods All men from the same geographical area with prostate volumes >= 80 ml treated 1999-2015 with CoreTherm and having BPO or were catheter-dependent due to chronic urinary retention, were included. End of study period was defined as December 31, 2019. Results We identified and evaluated 570 men treated with CoreTherm, where 12% (71 patients) were surgically retreated during the follow-up. Mean follow-up was 11 years, and maximum follow-up was 20 years. The long-term retreatment rate in our study was 23%. A majority of these could be retreated with CoreTherm or TURP, with only 3% requiring open surgery. Conclusion We conclude that CoreTherm is a suitable outpatient treatment option in patients with profoundly enlarged prostates, regardless of age, prostate size, and reason for treatment.

Subject headings and genre

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Urologi och njurmedicin hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Urology and Nephrology hsv//eng
Benign prostatic hyperplasia (BPH)
benign prostatic obstruction (BPO)
lower urinary tracts symptoms (LUTS)
TUMT
PLFT
CoreTherm
The
CoreTherm Concept
transurethral microwave thermotherapy
association symptom index
urinary retention
intraprostatic injections
enucleation
mepivacaine
epinephrine
resection
surgery
trial
Urology & Nephrology
Benign prostatic hyperplasia (BPH); benign prostatic obstruction (BPO); lower urinary tracts symptoms (LUTS); TUMT; PLFT; CoreTherm; The CoreTherm Concept

Added entries (persons, corporate bodies, meetings, titles ...)

Brudin, LarsLinköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Kalmar Cty Hosp, Sweden(Swepub:liu)larbr27 (author)
Kjölhede, Henrik,1981Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Univ Gothenburg, Sweden(Swepub:gu)xkjohe (author)
Peeker, Ralph,1958Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Univ Gothenburg, Sweden(Swepub:gu)xpeera (author)
Stranne, Johan,1970Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Univ Gothenburg, Sweden(Swepub:gu)xstraj (author)
Göteborgs universitetInstitutionen för kliniska vetenskaper, Avdelningen för urologi (creator_code:org_t)

Related titles

In:Scandinavian Journal of Urology: Medical Journals Sweden AB56:4, s. 336-3412168-18052168-1813

Internet link

Find in a library

Scandinavian Journal of Urology (Search for host publication in LIBRIS)

To the university's database

1 of 1
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Stenmark, Fredri ...; Brudin, Lars; Kjölhede, Henrik ...; Peeker, Ralph, 1 ...; Stranne, Johan, ...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Urology and Neph ...

Articles in the publication: Scandinavian Jou ...

By the university: University of Gothenburg; Linköping University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se